Status:
NOT_YET_RECRUITING
Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil
Lead Sponsor:
HOHM Foundation
Conditions:
Silicosis
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
This clinical study aims to address a research and clinical treatment gap related to individuals with symptoms of Silicosis resulting from quartzite mining work. Silicosis represents a challenge in th...
Detailed Description
The study design is a simple clinical trial to assess the effect of the homeopathic medication Silica 12CH given alongside the conventional treatment of Silicosis, versus standard treatment alone for ...
Eligibility Criteria
Inclusion
- To be eligible to participate, participants must meet the following criteria:
- must be at least 18 years old
- must have a clinical diagnosis of silicosis
- must be receiving conventional medical care and/or monitoring for their condition
Exclusion
- ● Individuals under the age of 18
- individuals who are not receiving conventional medical care and/or monitoring for their condition
- individuals too infirm to receive regular monitoring as required for the study
- Interested participants without Silicosis
- Individuals with Tuberculosis
- Individuals defined as part of a vulnerable group
- legal or clinically incapable persons
- person in a state of temporary disability;
- of a member of indigenous community
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06011785
Start Date
March 1 2024
End Date
March 1 2026
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HOHM Foundation
Philadelphia, Pennsylvania, United States, 19138